Loading...

Common Splendor International Health Industry Group

SEHK:286
Snowflake Description

Moderate growth potential with mediocre balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
286
SEHK
HK$1B
Market Cap
  1. Home
  2. HK
  3. Healthcare
Company description

Common Splendor International Health Industry Group Limited, an investment holding company, provides precision life healthcare services in the People’s Republic of China. The last earnings update was 54 days ago. More info.


Add to Portfolio Compare Print
  • Common Splendor International Health Industry Group has significant price volatility in the past 3 months.
286 Share Price and Events
7 Day Returns
-2.1%
SEHK:286
-1.5%
HK Healthcare
-2%
HK Market
1 Year Returns
-34.9%
SEHK:286
-22.4%
HK Healthcare
-13.2%
HK Market
286 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Common Splendor International Health Industry Group (286) -2.1% -5% -19.5% -34.9% -34% -25.8%
HK Healthcare -1.5% -5.7% -16.2% -22.4% -25.8% -6.3%
HK Market -2% -2.7% -9.8% -13.2% 18.1% 4.3%
1 Year Return vs Industry and Market
  • 286 underperformed the Healthcare industry which returned -22.4% over the past year.
  • 286 underperformed the Market in Hong Kong which returned -13.2% over the past year.
Price Volatility
286
Industry
5yr Volatility vs Market

Value

 Is Common Splendor International Health Industry Group undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Common Splendor International Health Industry Group. This is due to cash flow or dividend data being unavailable. The share price is HK$0.475.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Common Splendor International Health Industry Group's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Common Splendor International Health Industry Group's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
SEHK:286 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in HKD HK$0.00
SEHK:286 Share Price ** SEHK (2019-06-18) in HKD HK$0.48
Hong Kong Healthcare Industry PE Ratio Median Figure of 19 Publicly-Listed Healthcare Companies 15.11x
Hong Kong Market PE Ratio Median Figure of 1,488 Publicly-Listed Companies 10.66x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Common Splendor International Health Industry Group.

SEHK:286 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= SEHK:286 Share Price ÷ EPS (both in HKD)

= 0.48 ÷ 0.00

659.72x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Common Splendor International Health Industry Group is overvalued based on earnings compared to the HK Healthcare industry average.
  • Common Splendor International Health Industry Group is overvalued based on earnings compared to the Hong Kong market.
Price based on expected Growth
Does Common Splendor International Health Industry Group's expected growth come at a high price?
Raw Data
SEHK:286 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 659.72x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
32.7%per year
Hong Kong Healthcare Industry PEG Ratio Median Figure of 7 Publicly-Listed Healthcare Companies 1.04x
Hong Kong Market PEG Ratio Median Figure of 467 Publicly-Listed Companies 0.75x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Common Splendor International Health Industry Group, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Common Splendor International Health Industry Group's assets?
Raw Data
SEHK:286 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in HKD HK$0.25
SEHK:286 Share Price * SEHK (2019-06-18) in HKD HK$0.48
Hong Kong Healthcare Industry PB Ratio Median Figure of 35 Publicly-Listed Healthcare Companies 1.64x
Hong Kong Market PB Ratio Median Figure of 2,170 Publicly-Listed Companies 0.93x
SEHK:286 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= SEHK:286 Share Price ÷ Book Value per Share (both in HKD)

= 0.48 ÷ 0.25

1.9x

* Primary Listing of Common Splendor International Health Industry Group.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Common Splendor International Health Industry Group is overvalued based on assets compared to the HK Healthcare industry average.
X
Value checks
We assess Common Splendor International Health Industry Group's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Common Splendor International Health Industry Group has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Common Splendor International Health Industry Group expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover Common Splendor International Health Industry Group, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
32.7%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Common Splendor International Health Industry Group expected to grow at an attractive rate?
  • Common Splendor International Health Industry Group's earnings growth is expected to exceed the low risk savings rate of 2%.
Growth vs Market Checks
  • Common Splendor International Health Industry Group's earnings growth is expected to exceed the Hong Kong market average.
  • Unable to compare Common Splendor International Health Industry Group's revenue growth to the Hong Kong market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
SEHK:286 Future Growth Rates Data Sources
Data Point Source Value (per year)
SEHK:286 Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts 32.7%
Hong Kong Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 15.3%
Hong Kong Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 12.6%
Hong Kong Market Earnings Growth Rate Market Cap Weighted Average 11%
Hong Kong Market Revenue Growth Rate Market Cap Weighted Average 10.6%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
SEHK:286 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (5 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in HKD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
SEHK:286 Past Financials Data
Date (Data in HKD Millions) Revenue Cash Flow Net Income *
2018-12-31 377 8 2
2018-09-30 452 -34 2
2018-06-30 528 -75 3
2018-03-31 501 -62 2
2017-12-31 475 -50 1
2017-09-30 496 -90 8
2017-06-30 517 -131 14
2017-03-31 536 -128 28
2016-12-31 555 -124 42
2016-09-30 583 -4 51
2016-06-30 610 116 59
2016-03-31 570 116 47

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Common Splendor International Health Industry Group's earnings are expected to grow significantly at over 20% yearly.
  • Unable to determine if Common Splendor International Health Industry Group is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
SEHK:286 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (5 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Common Splendor International Health Industry Group Company Filings, last reported 5 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

SEHK:286 Past Financials Data
Date (Data in HKD Millions) EPS *
2018-12-31 0.00
2018-09-30 0.00
2018-06-30 0.00
2018-03-31 0.00
2017-12-31 0.00
2017-09-30 0.00
2017-06-30 0.01
2017-03-31 0.01
2016-12-31 0.02
2016-09-30 0.02
2016-06-30 0.02
2016-03-31 0.02

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Common Splendor International Health Industry Group will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Common Splendor International Health Industry Group's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Hong Kong market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Hong Kong market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Common Splendor International Health Industry Group has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Common Splendor International Health Industry Group performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Common Splendor International Health Industry Group's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Common Splendor International Health Industry Group's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.
  • Common Splendor International Health Industry Group's 1-year earnings growth exceeds its 5-year average (51.9% vs -2%)
  • Common Splendor International Health Industry Group's earnings growth has exceeded the HK Healthcare industry average in the past year (51.9% vs 8%).
Earnings and Revenue History
Common Splendor International Health Industry Group's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Common Splendor International Health Industry Group Company Filings, last reported 5 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

SEHK:286 Past Revenue, Cash Flow and Net Income Data
Date (Data in HKD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 377.04 2.16 65.32
2018-09-30 452.33 2.40 64.49
2018-06-30 527.62 2.64 63.66
2018-03-31 501.28 2.03 54.14
2017-12-31 474.93 1.42 44.62
2017-09-30 496.17 7.88 42.94
2017-06-30 517.41 14.33 41.26
2017-03-31 536.19 28.21 44.95
2016-12-31 554.96 42.10 48.64
2016-09-30 582.69 50.71 44.83
2016-06-30 610.43 59.33 41.02
2016-03-31 570.36 46.67 36.56
2015-12-31 530.29 34.01 32.11
2015-06-30 485.16 26.76 37.65
2015-03-31 422.49 23.60 35.46
2014-12-31 359.82 20.44 33.27
2014-06-30 17.10 -9.61 18.35
2014-03-31 12.81 -6.46 15.33
2013-12-31 8.53 -3.31 12.32
2013-09-30 9.28 0.62 28.01
2013-06-30 8.15 -7.82 43.63
2013-03-31 8.26 -9.70 41.28
2012-12-31 8.37 -11.59 38.93
2012-09-30 8.50 -1.70 21.08
2012-06-30 8.62 8.18 3.23

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Common Splendor International Health Industry Group has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Common Splendor International Health Industry Group used its assets less efficiently than the HK Healthcare industry average last year based on Return on Assets.
  • Common Splendor International Health Industry Group's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Common Splendor International Health Industry Group's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Common Splendor International Health Industry Group has a total score of 2/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Common Splendor International Health Industry Group's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Common Splendor International Health Industry Group's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Common Splendor International Health Industry Group is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Common Splendor International Health Industry Group's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Common Splendor International Health Industry Group's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 1.8x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Common Splendor International Health Industry Group Company Filings, last reported 5 months ago.

SEHK:286 Past Debt and Equity Data
Date (Data in HKD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 962.23 264.28 143.28
2018-09-30 962.23 264.28 143.28
2018-06-30 985.24 311.26 182.18
2018-03-31 985.24 311.26 182.18
2017-12-31 978.21 301.31 192.44
2017-09-30 978.21 301.31 192.44
2017-06-30 660.42 298.37 21.98
2017-03-31 660.42 298.37 21.98
2016-12-31 667.55 264.50 208.68
2016-09-30 667.55 264.50 208.68
2016-06-30 590.01 33.50 17.78
2016-03-31 590.01 33.50 17.78
2015-12-31 546.36 14.17 31.25
2015-06-30 484.59 0.00 20.01
2015-03-31 484.59 0.00 20.01
2014-12-31 457.79 0.02 8.08
2014-06-30 411.71 0.02 28.60
2014-03-31 411.71 0.02 28.60
2013-12-31 407.46 0.03 53.13
2013-09-30 407.46 0.03 52.34
2013-06-30 407.34 0.03 64.97
2013-03-31 407.34 0.03 64.97
2012-12-31 398.45 0.03 86.77
2012-09-30 398.45 0.03 86.77
2012-06-30 491.80 0.11 119.11
  • Common Splendor International Health Industry Group's level of debt (27.5%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (0% vs 27.5% today).
  • Debt is not well covered by operating cash flow (2.9%, less than 20% of total debt).
  • Interest payments on debt are not well covered by earnings (EBIT is 0.9x annual interest expense, ideally 3x coverage).
X
Financial health checks
We assess Common Splendor International Health Industry Group's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Common Splendor International Health Industry Group has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Common Splendor International Health Industry Group's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Common Splendor International Health Industry Group dividends.
If you bought HK$2,000 of Common Splendor International Health Industry Group shares you are expected to receive HK$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Common Splendor International Health Industry Group's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Common Splendor International Health Industry Group's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
SEHK:286 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Hong Kong Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 13 Stocks 2.5%
Hong Kong Market Average Dividend Yield Market Cap Weighted Average of 966 Stocks 3.7%
Hong Kong Minimum Threshold Dividend Yield 10th Percentile 1.2%
Hong Kong Bottom 25% Dividend Yield 25th Percentile 2.1%
Hong Kong Top 25% Dividend Yield 75th Percentile 5.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

SEHK:286 Past Annualized Dividends Data
Date (Data in HK$) Dividend per share (annual) Avg. Yield (%)
2013-09-23 0.000 0.000
2013-08-23 0.000 0.000
2013-04-02 0.000 0.000
2012-09-27 0.000 0.000
2012-08-31 0.000 0.000
2012-03-09 0.002 1.007
2011-09-08 0.002 1.282
2011-08-11 0.002 1.081
2011-03-17 0.002 0.877
2010-04-20 0.001 0.411
2010-03-16 0.001 0.312

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Common Splendor International Health Industry Group has not reported any payouts.
  • Unable to verify if Common Splendor International Health Industry Group's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Common Splendor International Health Industry Group's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Common Splendor International Health Industry Group has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Common Splendor International Health Industry Group's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Common Splendor International Health Industry Group afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Common Splendor International Health Industry Group has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Common Splendor International Health Industry Group's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Jiong Xian Ye
COMPENSATION HK$478,000
AGE 53
TENURE AS CEO 3.5 years
CEO Bio

Mr. Jiong Xian Ye has been the Chief Executive Officer of Common Splendor International Health Industry Group Limited since December 28, 2015 and as its Executive Director since December 18, 2015. Mr. Ye is a Chief Surgeon, Professor, Doctor in Management Studies and Doctoral Advisor. He has experience in the fields of clinical medicine, teaching, scientific research and management. He served as Senior Executive in a number of top class Grade A hospitals. Mr. Ye held administrative positions with health care authorities for a number of years, where he led the preparation work for setting up large general hospitals. Mr. Ye was sent to International Universities such as the Harvard University to study where he accumulated rich experience in health care management. At Harvard University, Mr. Ye is an Executive Director of the Hospital Architecture System Research Branch under the Chinese Hospital Association, the Editorial Board Member of the book titled Architecture and Equipment of Chinese Hospitals and the chief editor of the books titled Practices in Setting up Hospitals and Norms for Etiquette of Medical Workers. He won great awards in China.

CEO Compensation
  • Jiong Xian's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Jiong Xian's remuneration is lower than average for companies of similar size in Hong Kong.
Management Team

Kenny Cheung

TITLE
Chairman
COMPENSATION
HK$450K
AGE
44

Jiong Xian Ye

TITLE
CEO & Executive Director
COMPENSATION
HK$478K
AGE
53
TENURE
3.5 yrs

Hau Yan Cheng

TITLE
Deputy Chairman
COMPENSATION
HK$2M
AGE
71

Wing Cheung Wong

TITLE
Company Secretary & Financial Controller
Board of Directors Tenure

Average tenure and age of the Common Splendor International Health Industry Group board of directors in years:

4.9
Average Tenure
51.5
Average Age
  • The tenure for the Common Splendor International Health Industry Group board of directors is about average.
Board of Directors

Kenny Cheung

TITLE
Chairman
COMPENSATION
HK$450K
AGE
44
TENURE
6.8 yrs

Jiong Xian Ye

TITLE
CEO & Executive Director
COMPENSATION
HK$478K
AGE
53
TENURE
3.5 yrs

Hau Yan Cheng

TITLE
Deputy Chairman
COMPENSATION
HK$2M
AGE
71
TENURE
6.8 yrs

Yang Guang Mai

TITLE
Independent Non Executive Director
COMPENSATION
HK$150K
AGE
53
TENURE
6.3 yrs

Ernest Wong

TITLE
Independent Non-Executive Director
COMPENSATION
HK$150K
AGE
50
TENURE
1.8 yrs

Jiang Lin

TITLE
Non-Executive Director
COMPENSATION
HK$150K
AGE
54
TENURE
6.3 yrs

Chi Wing Lam

TITLE
Independent Non-Executive Director
COMPENSATION
HK$150K
AGE
38
TENURE
3.3 yrs

Kai Wen Hou

TITLE
Non-Executive Director
AGE
33
TENURE
2 yrs
Who owns this company?
Recent Insider Trading
  • Common Splendor International Health Industry Group insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (HK$) Value (HK$)
31. May 19 Sell Wenli Zhang Individual 31. May 19 31. May 19 -130,000,000 HK$0.48 HK$-62,399,869
11. Jan 19 Sell Wenli Zhang Individual 11. Jan 19 11. Jan 19 -5,000,000 HK$0.67 HK$-3,347,997
X
Management checks
We assess Common Splendor International Health Industry Group's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Common Splendor International Health Industry Group has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Is Common Splendor International Health Industry Group Limited's (HKG:286) 1.2% ROE Worse Than Average?

By way of learning-by-doing, we'll look at ROE to gain a better understanding of Common Splendor International Health Industry Group Limited (HKG:286). … Over the last twelve months Common Splendor International Health Industry Group has recorded a ROE of 1.2%. … See our latest analysis for Common Splendor International Health Industry Group?

Simply Wall St -

Is Common Splendor International Health Industry Group Limited (HKG:286) Investing Your Capital Efficiently?

To be precise, we'll consider its Return On Capital Employed (ROCE), as that will inform our view of the quality of the business. … What is Return On Capital Employed (ROCE)? … ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business.

Simply Wall St -

Should You Worry About Common Splendor International Health Industry Group Limited's (HKG:286) CEO Pay?

In 2015 Jiong Xian Ye was appointed CEO of Common Splendor International Health Industry Group Limited (HKG:286). … View our latest analysis for Common Splendor International Health Industry Group? … Our data indicates that Common Splendor International Health Industry Group Limited is worth HK$1.7b, and total annual CEO compensation is HK$478k.

Simply Wall St -

Need To Know: Common Splendor International Health Industry Group Limited (HKG:286) Insiders Have Been Selling Shares

So shareholders might well want to know whether insiders have been buying or selling shares in Common Splendor International Health Industry Group Limited (HKG:286). … See our latest analysis for Common Splendor International Health Industry Group. … The Last 12 Months Of Insider Transactions At Common Splendor International Health Industry Group.

Simply Wall St -

Did You Manage To Avoid Common Splendor International Health Industry Group's 22% Share Price Drop?

Unfortunately the Common Splendor International Health Industry Group Limited (HKG:286) share price slid 22% over twelve months. … View our latest analysis for Common Splendor International Health Industry Group. … Unhappily, Common Splendor International Health Industry Group had to report a 83% decline in EPS over the last year.

Simply Wall St -

Should We Be Cautious About Common Splendor International Health Industry Group Limited's (HKG:286) ROE Of 1.7%?

By way of learning-by-doing, we'll look at ROE to gain a better understanding of Common Splendor International Health Industry Group Limited (HKG:286). … Common Splendor International Health Industry Group has a ROE of 1.7%, based on the last twelve months. … See our latest analysis for Common Splendor International Health Industry Group?

Simply Wall St -

What You Must Know About Common Splendor International Health Industry Group Limited's (HKG:286) Financial Strength

Investors are always looking for growth in small-cap stocks like Common Splendor International Health Industry Group Limited (HKG:286), with a market cap of HK$2.0b. … However, an important fact which most ignore is: how financially healthy is the business? … So, understanding the company's financial health becomes

Simply Wall St -

What Kind Of Shareholder Appears On The Common Splendor International Health Industry Group Limited's (HKG:286) Shareholder Register?

Every investor in Common Splendor International Health Industry Group Limited (HKG:286) should be aware of the most powerful shareholder groups. … With a market capitalization of HK$1.9b, Common Splendor International Health Industry Group is a small cap stock, so it might not be well known by many institutional investors. … Check out our latest analysis for Common Splendor International Health Industry Group

Simply Wall St -

Does Common Splendor International Health Industry Group Limited's (HKG:286) CEO Salary Compare Well With Others?

Jiong Xian Ye became the CEO of Common Splendor International Health Industry Group Limited (HKG:286) in 2015. … Check out our latest analysis for Common Splendor International Health Industry Group? … Our data indicates that Common Splendor International Health Industry Group Limited is worth HK$2.1b, and total annual CEO compensation is HK$478k.

Simply Wall St -

Should We Be Cautious About Common Splendor International Health Industry Group Limited's (HKG:286) ROE Of 1.7%?

We'll use ROE to examine Common Splendor International Health Industry Group Limited (HKG:286), by way of a worked example. … Our data shows Common Splendor International Health Industry Group has a return on equity of 1.7% for the last year. … See our latest analysis for Common Splendor International Health Industry Group?

Simply Wall St -

Company Info

Description

Common Splendor International Health Industry Group Limited, an investment holding company, provides precision life healthcare services in the People’s Republic of China. It operates through two segments, Health Industry, and Investment and Finance. The company offers medical anti-aging and health preservation base services. It also engages in medical and healthcare industry investment management, natural health food trading, bio-medical technology, and investment and finance businesses. The company was formerly known as G-Prop (Holdings) Limited and changed its name to Common Splendor International Health Industry Group Limited in December 2013. Common Splendor International Health Industry Group Limited was incorporated in 1990 and is based in Tsim Sha Tsui, Hong Kong.

Details
Name: Common Splendor International Health Industry Group Limited
286
Exchange: SEHK
Founded: 1990
HK$1,423,221,128
2,996,255,008
Website: http://www.cs-ih.com
Address: Common Splendor International Health Industry Group Limited
North Tower,
Room 2709-10, 27th Floor,
Tsim Sha Tsui,
Kowloon, Hong Kong
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
SEHK 286 Ordinary Shares The Stock Exchange of Hong Kong Ltd. HK HKD 02. Jan 1992
Number of employees
Current staff
Staff numbers
200
Common Splendor International Health Industry Group employees.
Industry
Health Care Services
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/06/19 12:44
End of day share price update: 2019/06/18 00:00
Last earnings filing: 2019/04/26
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.